Page last updated: 2024-09-05

lapatinib and Chromosome-Defective Micronuclei

lapatinib has been researched along with Chromosome-Defective Micronuclei in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abo-Elfadl, MT; Abo-Zeid, MAM; Gamal-Eldeen, AM	1

Other Studies

1 other study(ies) available for lapatinib and Chromosome-Defective Micronuclei

Article	Year
Evaluation of lapatinib cytotoxicity and genotoxicity on MDA-MB-231 breast cancer cell line. Environmental toxicology and pharmacology, 2019, Volume: 71 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Inhibitory Concentration 50; Lapatinib; Micronuclei, Chromosome-Defective; Time Factors; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53	2019

Article

Year

Evaluation of lapatinib cytotoxicity and genotoxicity on MDA-MB-231 breast cancer cell line.

Environmental toxicology and pharmacology, 2019, Volume: 71

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Inhibitory Concentration 50; Lapatinib; Micronuclei, Chromosome-Defective; Time Factors; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2019